Service Providers And Pharmacists
TB Coordinator: Diane Freedman, RN PHN - 775-785-4787
Tuberculosis is a Reportable Illness.
Tuberculosis is a Reportable Illness – 441A.225 and 441A.352
Timely reporting by all responsible providers is crucial to ensuring effective treatment of all persons diagnosed with or suspected to have active Tuberculosis disease and for the evaluations of exposed persons (contacts).
Tuberculosis continues to be a public health threat; it remains the second leading cause of death among infectious diseases in the world. Although United States has achieved great strides in reducing the number of cases in the US we are still far from elimination. We need to continue collaborative efforts to one day achieve the goal of TB elimination.
Please report tuberculosis (confirmed and suspected) within 24 hours to the Washoe County Health District, Communicable Disease Program. Phone: 775-328-2447 or Fax: 775-328-3764. Confidential case report - Communicable disease report for Health Care Providers and Laboratory TB Medication Dispensing form for Pharmacists.
- Reporting Requirements Protocol Guidelines for Infection Control of Hospitalized TB Patients
- Reporting of Communicable Diseases
How Can You Help Control TB?
- Identify test and treat. Actively identify and test your patients who are most likely to be infected with TB or who are at increased risk of developing TB if they are infected. Offer treatment to your patients with latent tuberculosis infection (LTBI) and encourage them to complete the full regimen.
- Persons at risk for TB infection:
- Contacts to TB case - especially children under 5 years
- Foreign-born persons from endemic countries (Such as China, India, Mexico, the Philippines, and Vietnam)
- Persons who have lived in endemic countries
- Conditions that increase the risk of LTBI progressing to TB
- HIV infection - the strongest known risk factor
- Diabetes mellitus
- Immune system disorders
- Use of TNF - antagonists (infliximab, etanercept and adalimumab)
- Recent TB infection - the greatest risk for progression to TB is in the first 2 years after infection
- Recent immigration - persons from endemic countries who have been in the US for less than 5 years have a 4 times greater risk of developing TB than those who have been in the US more than 5 years
- Persons who are 10% or more below ideal body weight
- End stage renal disease
- Gastrectomy/jejunoileal bypass
- Organ transplant
- Persons at risk for TB infection:
- Use DOT. Directly Observed Therapy is the gold standard of care for treating persons with TB disease. DOT is the most effective strategy for ensuring completion of treatment, preventing multi-drug resistant TB and preventing severe complications.
- Ask for assistance. We welcome your questions and referrals. We are delighted to share our knowledge and resources and extend consultation from our board-certified pulmonary specialists.
- Provide education for patients & health care providers. Order free CDC materials.
New TB Regimen
- CDC guidelines, Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection (MMWR 2011; 60: 1650-1653).
- CDC press release
- Reference from the New England Journal of Medicine, December 8, 2011: Sterling TR, Villarino, ME, Borisov, AS et. al. "Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection."
- This regimen requires DOT (Directly Observed Therapy). Please call us for assistance.
TBPCP Coordinator: Diane Freedman, RN, PHN - 775-785-4785
TB Case Managers:
Judy Medved-Gonzalez, RN, PHN - 775-785-4789
Holly McGee, RN, PHN - 775-785-4785
Homeless: Diane Freedman, RN, PHN - 775-785-4785
Immigration: Diane Freedman, RN, PHN - 775-785-4785
Infection Control: Judy Medved-Gonzalez, RN, PHN - 775-785-4789
WC Detention Facility: Holly McGee, RN, PHN - 775-785-4785
TB/HIV: Judy Medved-Gonzalez, RN, PHN - 775-785-4789
We accept referrals for evaluation of persons with TB symptoms; treatment of persons with TB disease and treatment of persons with latent TB infection at risk for progressing to TB disease. Referrals are also accepted for treatment of LTBI utilizing the Rifapentine and Isoniazid 12 week regimen (3HP). Please contact Diane, Judy or Holly at the numbers listed above.
- www.cdc.gov/tb/ - Up-to-date guidelines and recommendations from the Center for Disease Control and Prevention
- www.who.int/tb/en - Information on global TB from the World Health Organization
- www.stoptb.org - Information on the Global Stop TB Plan. Videos.
- www.lungusa.org - American Lung Association
- Nevada State Health Division
- www.findtbresources.org - TB training materials
- www.currytbcenter.ucsf.edu - Francis J. Curry National Tuberculosis Center - regional TB information and training opportunities, including on-line courses.
- www.currytbcenter.ucsf.edu/products/tbradiographic.cfm - Radiographic Manifestations of Tuberculosis: A Primer for Clinicians, Second Edition
- (877) 390-NOTB [(877) 390-6682] Francis J. Curry National Tuberculosis Center Warmline - Tuberculosis experts answer questions about Tuberculosis Monday-Friday, 8:30am - 4:30pm.
Epi-News Issues Featuring Tuberculosis
- 3/5/2014 - Reporting of Communicable Diseases
- 3/23/2012 - World TB Day March 24
- 12/23/2011 - LTBI 12 Dose Regimen
- 03/23/2011 - World TB Day 2011
- 03/23/2010 - World TB Day 2010
- 12/21/2009 - Reporting Requirements Protocol Guidelines for Infection Control of Hospitalized TB Patients
- 3/24/2009 - World TB Day 2009
- 3/21/2008 - World TB Day 2008
- 1/15/2008 - Tuberculosis - Adaptability through the centuries
- 7/27/2007 - A New Test for Tuberculosis - QuantiFERON® - TB Gold
- 3/17/2006 - World TB Day 2006
- 3/21/2005 - World TB Day 2005